Ondansetron 4MG and 8MG
SPE2D223R0007 · DEPT OF DEFENSE
A PHARMACEUTICAL PREPARATION MANUFACTURING solicitation. AwardCast estimates what this specific solicitation will close for, before you bid.
SPE2D223R0007
solicitation
325412
NAICS
6505
PSC
Not set aside
set-aside
What's being bought
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Ondansetron. Procurement details follow. Ondansetron HCL 4 and 8MG Tablets and Ondansetron HCL 4 and 8 MG Tablets, DIS. This will be an unrestricted and fully competitive acquisition. The contra
Comparable recent awards in PHARMACEUTICAL PREPARATION MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| SR-SERVICES GMBH | $25K | 2 | 2024-09-30 |
| AMERICAN REGENT INC | $926 | n/a | 2024-09-30 |
| PFIZER INC | $2.2M | 4 | 2024-09-30 |
| ADVANCED ACCELERATOR APPLICATIONS USA INC | $1.9M | n/a | 2024-09-30 |
| FRESENIUS KABI USA, LLC | $5.4M | 4 | 2024-09-30 |
Explore the market
Comparable awards ran from $926 to $5.4M. Get AwardCast's forecast for THIS solicitation's closing price.
AwardCast forecasts what U.S. federal contracts close for, before you bid. Built on USASpending and SAM.gov. Not affiliated with the U.S. government. Technology by Chosing DEPT.